Eight Capital Lowers Andlauer Healthcare Group (TSE:AND) Price Target to C$51.00

Andlauer Healthcare Group (TSE:ANDGet Free Report) had its price target dropped by equities researchers at Eight Capital from C$58.00 to C$51.00 in a research note issued on Friday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Eight Capital’s price objective suggests a potential upside of 21.89% from the stock’s previous close.

A number of other brokerages also recently weighed in on AND. Scotiabank dropped their target price on shares of Andlauer Healthcare Group from C$46.00 to C$45.00 and set a “sector perform” rating for the company in a research note on Friday. Royal Bank of Canada dropped their target price on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating for the company in a research note on Monday, May 6th. TD Securities dropped their target price on shares of Andlauer Healthcare Group from C$54.00 to C$52.00 and set a “buy” rating for the company in a research note on Monday, May 6th. CIBC dropped their target price on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an “outperform” rating for the company in a research note on Monday, May 6th. Finally, Stifel Nicolaus dropped their target price on shares of Andlauer Healthcare Group from C$55.00 to C$52.00 and set a “buy” rating for the company in a research note on Monday, May 6th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of C$48.57.

View Our Latest Report on AND

Andlauer Healthcare Group Price Performance

TSE:AND traded down C$0.02 on Friday, reaching C$41.84. The stock had a trading volume of 17,853 shares, compared to its average volume of 34,846. The company has a market capitalization of C$815.04 million, a P/E ratio of 27.71 and a beta of 0.69. Andlauer Healthcare Group has a 1-year low of C$36.43 and a 1-year high of C$44.76. The company has a quick ratio of 1.66, a current ratio of 1.94 and a debt-to-equity ratio of 26.06. The stock has a fifty day moving average price of C$39.00 and a 200-day moving average price of C$40.30.

Andlauer Healthcare Group (TSE:ANDGet Free Report) last announced its earnings results on Thursday, May 2nd. The company reported C$0.35 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.53 by C($0.18). Andlauer Healthcare Group had a return on equity of 13.82% and a net margin of 10.02%. The company had revenue of C$161.14 million during the quarter, compared to the consensus estimate of C$168.50 million. Research analysts forecast that Andlauer Healthcare Group will post 1.6396243 EPS for the current year.

Insider Buying and Selling

In other Andlauer Healthcare Group news, Director Ronald Martin Skelton sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of C$40.87, for a total value of C$61,309.95. 1.43% of the stock is currently owned by insiders.

About Andlauer Healthcare Group

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Featured Articles

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.